Advertisement
Advertisement
NSPR
InspireMD, Inc.
0.70
USDSponsored
+0.06
+8.92%
Nov 06, 15:59 UTC -5
Closed
After-Market
0.69
-0.01
-1.15%
InspireMD, Inc. (NSPR) Earnings
NSPR Earnings Reports
Positive Surprise Ratio
NSPR beat 27 of 33 last estimates.
82%
Next Report
Next Week
Date of Next Report
Nov 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.04M
/-$0.15
Implied change from Q2 26 (Revenue/ EPS)
+14.98%
/-11.76%
Implied change from Q3 25 (Revenue/ EPS)
-19.29%
/-11.76%
InspireMD, Inc. earnings per share and revenue
On Aug 14, 2026, NSPR reported earnings of -0.17 USD per share (EPS) for Q2 26, beating the estimate of -0.20 USD, resulting in a 16.67% surprise. Revenue reached 1.77 million, compared to an expected 1.41 million, with a 25.45% difference. The market reacted with a -10.44% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 2.04 million USD, implying an decrease of -11.76% EPS, and increase of 14.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
SiNtx Technologies, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.31
Actual
-$0.24
Surprise
+23.27%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
FAQ
What were InspireMD, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, InspireMD, Inc. reported EPS of -$0.17, beating estimates by 16.67%, and revenue of $1.77M, 25.45% above expectations.
How did the market react to InspireMD, Inc.'s Q2 2026 earnings?
The stock price moved down -10.44%, changed from $0.98 before the earnings release to $0.88 the day after.
When is InspireMD, Inc. expected to report next?
The next earning report is scheduled for Nov 12, 2026.
What are the forecasts for InspireMD, Inc.'s next earnings report?
Based on 4
analysts, InspireMD, Inc. is expected to report EPS of -$0.15 and revenue of $2.04M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.